Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002265.SZ
Valuation Weak
28%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Bad
0%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -3.74 1.27 1.32
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -119.95 -33.54 -15.25
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.75 3.28 3.25
Cash -14.48 1.76 2.06
Capex 48.00 -0.02 -0.03
Free Cash Flow -22.49 -0.46 0.59
Revenue -23.85 0.81 1.06
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -53.54 0.12 0.25
Operating Margin -85.38 -0.01 0.10
ROA -77.20 < 0.005 0.01
ROE -77.17 < 0.005 0.03
ROIC -91.39 < 0.005 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002265.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002265.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002265.SZ is permitted for members.